Ipamorelin Purity: 1801 Lab Tests Across 637 Identified Manufacturers
45 studies on Ipamorelin curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently tracks 1,801 published third-party lab tests of Ipamorelin across 637 identified manufacturers. Among reports with a positive numeric purity result, the average is 99.52%. Within this published corpus, 10 positive purity results were below 90%, and 143 reports showed measured quantity more than 10% below the label claim. These are batch-level observations, not guarantees of product identity, safety, or vendor quality.
Ipamorelin average prices
As of 2026-09-03, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 5 mg | $6.60 | $5.50–$8.00 | $1.32 | 5 sources · 5 offers |
| 10 mg | $11.33 | $10.50–$12.00 | $1.13 | 3 sources · 3 offers |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. The refresh date is the catalog build date; individual source observation dates are not available in this snapshot. View full price methodology →
We tested 1801 Ipamorelin batches across 637 identified manufacturers
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
Within that total, 386 batches have unresolved manufacturer identity. They remain in corpus-level lab evidence and are excluded from named-manufacturer rankings.
Top 3 vendor evidence profiles for Ipamorelin
Eligible vendors have at least 2 deduplicated tests and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and test count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes tested batches, not every product or shipment, and is not an endorsement.
| Rank | Manufacturer | Tests | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 37 | 99.61% | 0 of 31 (0.0%) 0 0% / not detected · 0 wrong compound · 6 unclassified | Reveal with Pro → | |
| #2 | 20 | 99.83% | 0 of 17 (0.0%) 0 0% / not detected · 0 wrong compound · 3 unclassified | Reveal with Pro → | |
| #3 | 17 | 99.61% | 0 of 17 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → |
Manufacturer identities are included with Pro. Batch counts and lab measurements remain visible.
Recent certificates: #101340 (99.65%) · #100418 (99.95%) · #100778 (99.87%) · #100813 (99.58%) · #100837 (99.69%) · #100853 (99.98%)
Ipamorelin studies and clinical research
-
GLP-1R Agonists Show Reproducible Evidence for Knee Osteoarthritis Symptom Relief, While Other Peptides Lack High-Quality Data
This review highlights a critical distinction for peptide users and clinicians: only GLP-1R agonists currently possess reproducible, high-quality evidence for a specific musculoskeletal indication (knee osteoarthritis…
-
Advanced Method Detects Growth Hormone Releasing Peptides in Athlete Urine
This study provides crucial evidence of the ongoing misuse of GHRP-2 and GHRP-6 in sports and validates a robust analytical method for their detection. The ability to accurately identify these peptides in athlete urin…
-
New Analytical Methods Improve Detection of Growth Hormone Secretagogues in Anti-Doping
Improved and more sensitive detection methods are paramount for maintaining the integrity and fairness of competitive sports. By identifying novel metabolites and optimizing analytical protocols, this research signifi…
-
New Ipamorelin Analogs Show Enhanced Growth Hormone Release Potency and Selectivity
-
Scientists Discover Novel Orally Active Growth Hormone Secretagogues
The discovery of these novel, orally active growth hormone secretagogues represents a significant advancement in the field of endocrinology and drug development. Oral administration offers a more convenient and patien…
-
Ipamorelin: A Novel Selective Peptide Boosts Growth Hormone Without Side Effects
This study marks a significant advancement by identifying Ipamorelin as the first truly selective growth hormone secretagogue, offering a cleaner pharmacological profile. The absence of significant prolactin or cortis…
-
Understanding Ipamorelin's Absorption: A Look at Nasal Delivery for Growth Hormone Release
-
Ipamorelin Peptide Promotes Bone Growth in Young Rats by Releasing Growth Hormone
This research highlights Ipamorelin's potential as a potent and selective growth hormone secretagogue capable of directly stimulating bone growth. Its efficacy, comparable to recombinant human GH in this model, sugges…
-
New Oral Compound NN703 Potently Stimulates Growth Hormone Release
The discovery of NN703 as a potent and orally bioavailable GH secretagogue represents a significant advancement in the field of endocrinology. An oral GH secretagogue could revolutionize the treatment paradigm for con…
-
Ipamorelin's Growth Hormone Release Profile Mapped in Healthy Humans
This research provides critical insights into the pharmacology of ipamorelin, establishing a robust quantitative link between its systemic exposure and its growth hormone-releasing effects in humans. Understanding thi…
-
Methylprednisolone Does Not Block Growth Hormone Release from Novel Secretagogue in Rats
This finding is highly significant because it suggests that this novel GHS could potentially be effective even in individuals undergoing glucocorticoid therapy, where GH secretion is often suppressed. This could open …
-
GH Secretagogues Ipamorelin and GHRP-6 Significantly Boost Bone Mineral Content in Adult Female Rats
This foundational research is profoundly significant as it underscores the promising potential of GH secretagogues as a novel therapeutic strategy for managing and preventing conditions characterized by bone loss, suc…
-
GH Secretagogues Boost Body Fat Independently of Growth Hormone in Mice
This study reveals a critical GH-independent mechanism by which GHSs can increase body fat, potentially driven by increased feeding and altered metabolic signaling. This finding is highly significant for understanding…
-
Growth Hormone-Releasing Peptides May Act Through Ghrelin in the Stomach
This research provides a crucial mechanistic insight into how GHRPs stimulate growth hormone release, suggesting a significant interaction with the body's endogenous ghrelin system. Understanding this pathway could le…
-
Ghrelin Derivatives Reveal Smallest Potent Growth Hormone Secretagogue Core
This research significantly deepens our understanding of ghrelin's structure-activity relationship, particularly concerning its minimal active core and the critical role of specific amino acid positions. The identific…
-
New Hybrid Peptides Unlock Super-Potent Growth Hormone Release
This research highlights a successful strategy for designing highly potent growth hormone secretagogues by combining structural features from different active compounds. The discovery that re-introducing specific mole…
-
Ipamorelin Counteracts Glucocorticoid-Induced Bone Loss and Muscle Weakness in Rats
This research highlights Ipamorelin's potential to mitigate severe side effects of glucocorticoid therapy, which are widely used but often limited by their catabolic impact on bone and muscle. By demonstrating that Ip…
-
Chronic Ipamorelin Treatment Enhances Growth Hormone Release in Young Female Rats
This study provides crucial insights into the long-term effects of Ipamorelin on the pituitary, demonstrating that chronic administration can lead to a sustained enhancement of somatotroph function and GH release capa…
-
Novel Growth Hormone Secretagogues Show Enhanced Potency and Oral Bioavailability
This research successfully identified novel growth hormone secretagogues with significantly improved potency and, crucially, excellent oral bioavailability. The development of orally active GHS is a major step forward…
-
Diabetic Mice Show Growth Hormone Hypersecretion and Receptor Resistance to Secretagogues
This study highlights a critical paradox in diabetes: GH hypersecretion coexisting with peripheral GH receptor resistance. This finding suggests that the body attempts to compensate for impaired GH signaling by increa…
-
Growth Hormone Secretagogues Boost Fish GH Release Without Activating Genes
-
Ipamorelin Stimulates Insulin Release in Normal and Diabetic Rat Pancreas
This research is significant because it identifies a novel role for Ipamorelin beyond its known growth hormone-releasing effects, demonstrating its ability to directly stimulate insulin secretion. The finding that Ipa…
-
Seabream Ghrelin Gene Uncovered: Insights into Fish Appetite Regulation
This research provides the first comprehensive molecular characterization of ghrelin in seabream, a commercially important aquaculture species. Understanding the genetic structure and regulatory elements of seabream g…
-
Growth Hormone and Secretagogues Counter Steroid-Induced Muscle Wasting in Rats
This study provides compelling evidence that both growth hormone and growth hormone secretagogues can effectively mitigate the severe catabolic effects of steroid treatment, specifically by improving nitrogen balance …
-
Ipamorelin, a Ghrelin Mimetic, Accelerates Gut Recovery After Surgery in Rodents
This study provides compelling evidence that ipamorelin, a novel ghrelin mimetic, can effectively mitigate the symptoms and accelerate recovery from postoperative ileus in a preclinical model. The observed improvement…
-
New LC-MS Method Detects Growth Hormone Releasing Peptides in Human Urine for Doping Control
This study provides a highly sensitive and robust analytical tool that significantly enhances the capabilities of anti-doping laboratories to detect GHRP abuse. By simultaneously identifying both parent GHRPs and thei…
-
Ipamorelin Improves Gastric Motility in Postoperative Ileus Rodent Model
This research highlights ipamorelin's potential as a novel therapeutic agent for managing postoperative ileus by directly addressing gastric dysmotility and associated inflammation. Its ability to accelerate gastric e…
-
New Method Detects 11 Prohibited Peptides in Urine for Anti-Doping
This advanced analytical method significantly enhances anti-doping efforts by providing a highly sensitive, robust, and expandable tool for detecting a broad panel of small prohibited peptides. The ability to detect t…
-
Unraveling How Growth Hormone Releasing Peptides Break Down in the Body
Understanding these specific metabolic pathways is crucial for anti-doping efforts, enabling the development of more sensitive and specific detection methods for the misuse of performance-enhancing GHRPs. This researc…
-
New High-Throughput Method Detects Growth Hormone Releasing Peptides in Urine
This advanced analytical method provides a crucial tool for anti-doping agencies to combat the illicit use of GHRPs in both equine and human sports. By enabling reliable and high-throughput detection, it helps ensure …
-
Ipamorelin Accelerates Bowel Recovery After Surgery, Reducing Postoperative Ileus
This study provides compelling early evidence that ipamorelin, by mimicking the action of ghrelin (a hormone that stimulates appetite and GI motility), can effectively accelerate gastrointestinal recovery after bowel …
-
Detecting Growth Hormone Releasing Peptide Metabolites in Human Urine After Nasal Use
This research significantly enhances anti-doping capabilities by providing specific, long-lasting biomarkers for GHRPs administered nasally. The identification of these metabolites means that athletes misusing these s…
-
Peptide Structure-Activity Insights Reveal Keys to Growth Hormone Secretagogue Potency
This detailed structure-activity relationship analysis provides invaluable insights for the rational design of next-generation peptidic growth hormone secretagogues. Understanding how specific amino acid changes impac…
-
Novel Container Improves Urine Sample Stability for Doping Control
This pilot study provides compelling evidence that a specialized doping control container can substantially enhance the stability of urine samples, ensuring the accurate detection of prohibited substances over extende…
-
Black Market Growth Products Often Mislabeled, Contaminated, and Dangerous
This study unequivocally highlights the severe public health risks associated with the use of unregulated black market growth-promoting products. Consumers are frequently exposed to mislabeled, contaminated, or entire…
-
New Glycine-Modified Growth Hormone Secretagogues Found in Seized Doping Materials
This groundbreaking discovery represents a significant new challenge for global anti-doping agencies and laboratories, as these glycine-modified GHSs are unlikely to be detected by current, standard screening protocol…
-
Novel Boron-Rich Peptides Show Enhanced Stability, Potentially Activating Ghrelin Receptor
This research demonstrates that incorporating a meta-carborane scaffold can effectively improve the metabolic stability of peptide agonists without compromising their potency or selectivity for the ghrelin receptor. T…
-
Novel Peptidomimetics Enable Advanced Ghrelin Receptor PET Imaging
-
Growth Hormone Secretagogues: A New Path for Hypogonadal Men's Body Composition
This review underscores the potential of growth hormone secretagogues as a valuable therapeutic option for managing body composition in hypogonadal males, especially those who may not fully respond to or tolerate trad…
-
Ghrelin Mimetics Show Promise in Reducing Visceral and Somatic Pain
-
Ghrelin Agonist Ipamorelin Boosts Reproductive Hormones in Cichlid Fish
This research is significant as it expands our understanding of ghrelin's role beyond metabolism and growth, specifically highlighting its influence on reproductive physiology in non-mammalian vertebrates. For the aqu…
-
Growth Hormone Peptides Prevent Chemotherapy Weight Loss and Nausea in Ferrets
This research highlights the significant potential of GHS-R1a agonists like anamorelin and ipamorelin as novel therapeutic agents for managing chemotherapy-induced cachexia and emesis. The dual benefit of anamorelin i…
-
Ipamorelin: A Selective Peptide for Boosting Growth Hormone, Muscle, and Bone
These findings suggest that Ipamorelin could be a promising therapeutic agent for conditions characterized by growth hormone deficiency, sarcopenia, or osteoporosis. Its selective action as a growth hormone secretagog…
-
Ipamorelin Shows Promise for Speeding Recovery from Post-Surgery Bowel Paralysis
This study provides compelling evidence that ipamorelin can significantly accelerate recovery from post-operative ileus, offering a potential breakthrough in managing this common surgical complication. The observed 35…
-
Ipamorelin Explored for Faster Post-Surgery Gut Recovery
Research tools
Free, no account — handy when you're working with Ipamorelin.
